Description: Bumrungrad Hospital Public Company Limited (the ÂCompanyÂ) operates a private hospital business in Bangkok with the current capacity of 487 beds and over 4,500 outpatients per day. The Company is one of the leading healthcare providers in Thailand and in the Southeast Asian region, providing complete healthcare services for both outpatients and inpatients. The Company has always emphasized the importance of quality healthcare and experienced physicians and staff. Bumrungrad International Hospital, Bangkok is the first hospital in Asia to receive the US standard accreditation from the Joint Commission International (JCI). The hospital has also received JCIÂs Clinical Care Program Certification (CCPC) for specialties programs including the Primary Stroke Program, Acute Myocardial Infarction, Diabetes Mellitus Type I and II and Chronic Kidney Disease Stage I to IV. Besides, the Company is the first hospital which was approved by Thai Hospital Accreditation (HA).
Home Page: www.bumrungrad.com
33 Sukhumvit Soi 3 (Nana Nua)
Bangkok,
10110
Thailand
Phone:
66 2 066 8888
Officers
Name | Title |
---|---|
Ms. Linda Lisahapanya | President, MD & Executive Director |
Ms. Artirat Charukitpipat | Chief Executive Officer |
Ms. Oraphan Buamuang CPA | Chief Financial Officer |
Dr. Nipat Kulabkaw | Chief Operating Officer |
Ms. Supawan Sirinuntawit | Accounting Manager |
Dr. Polakit Teekakirikul M.D. | Chief Science Officer |
Mr. Daniel Kastner | Chief Transformation Office & Head of IR |
Dr. Aniello M. Sorrentino Ph.D. | Corporate Chief Strategy Officer |
Mr. David T. Boucher FACHE, M.P.H. | Chief Business Transformation Officer |
Tanee Maneenut | Chief Business Development Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Providers & Services |
GIC Sub-Industry: | Health Care Facilities |
Forward PE: | 21.5983 |
---|---|
Trailing PE: | 32.3077 |
Price-to-Book MRQ: | 7.3334 |
Price-to-Sales TTM: | 0.2901 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 0 |